The novel coronavirus has threatened public health across the globe, with mandatory quarantines and restricted travel creating complicated business environments. The Aktana team in China has been on the front lines since January helping our impacted clients quickly adapt to maintain go-to-market strategies and relationships with healthcare providers (HCPs).

As many cities in China rolled out measures to contain the spread of coronavirus, pharmaceutical companies found themselves in a position that required them to become instantly agile. How could they ensure timely communication to the field about changing regulations? And as face-to-face visits became more challenging, how could they increase usage of digital channels?

Hear Henry Sun, GM of China, and Eric Zhu, Head of Customer Success, share insights on these topics and more in order to ensure open and consistent communication with HCPs.

To view the webinar, select your region:

North AmericaEuropeJapan